People: Abbott Laboratories (ABT)
2 Jul 2015
Dr. John M. Capek, Ph.D. has been appointed as Executive Vice President - Ventures of the Company, effective June 1, 2015. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.
|Total Annual Compensation, USD||1,350,610|
|Restricted Stock Awards, USD||904,024|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,544,760|
|Fiscal Year Total, USD||3,799,400|